In line with these findings, deletion of GLP-1Rs in paired-like homeobox 2b (PHOX2B)-expressing neurons, which mark all vagal sensory afferents, minimally affects the acute appetite suppressing effects of exendin-4 and only partially prevents the weight loss caused by chronic treatment with the GLP-1R agonist dulaglutide [35]
And its a history with its share of ignominy: In the mid-1990s, a drug that combined fenfluramine and phentermine, known as fen-phen, exploded in popularity after a single, 121-patient study showed it was effective for weight loss
This strategy offers a novel avenue for SIN-targeted de-livery via the bone-brain axis, holding significant promise for ischemic brain therapy
As we get older, this absorption problem compounds: the body's ability to absorb nutrients through digestion decreases progressively, and some adults become completely unable to absorb B12 orally regardless of dose